Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06).
Masuyama M, Masuda N, Kawaguchi H, Yamamoto Y, Saji S, Nakayama T, Aogi K, Anan K, Ohtani S, Sato N, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita T, Yotsumoto D, Toi M, Ohno S. Masuyama M, et al. Among authors: kawaguchi h. Cancer Med. 2023 Sep;12(17):17718-17730. doi: 10.1002/cam4.6390. Epub 2023 Aug 1. Cancer Med. 2023. PMID: 37525895 Free PMC article.
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03).
Kobayashi K, Masuda N, Mizuno T, Miura K, Tokuda Y, Yoshinami T, Kawaguchi H, Ohtani S, Saeki T, Toi M, Takeuchi M, Ito Y. Kobayashi K, et al. Among authors: kawaguchi h. Breast Cancer Res Treat. 2023 Oct;201(3):409-415. doi: 10.1007/s10549-023-07030-x. Epub 2023 Jul 22. Breast Cancer Res Treat. 2023. PMID: 37480384 Clinical Trial.
[Statistical study on malignant tumors in young persons].
Yagi M, Masuda N, Kawaguchi H, Okamoto Y, Hirayama K. Yagi M, et al. Among authors: kawaguchi h. Jibiinkoka. 1969 Jan;41(1):45-8. Jibiinkoka. 1969. PMID: 5813782 Japanese. No abstract available.
Gestational diabetes in early pregnancy is associated with postpartum glucose intolerance: A perspective from the diabetes and pregnancy outcome for mother and baby study in Japan.
Yokoyama M, Miyakoshi K, Iwama N, Yamashita H, Yasuhi I, Kawasaki M, Arata N, Sato S, Imura Y, Waguri M, Kawaguchi H, Masaoka N, Nakajima Y, Hiramatsu Y, Sugiyama T; DREAMBee Study Gestational Diabetes Mellitus Group. Yokoyama M, et al. Among authors: kawaguchi h. J Diabetes Investig. 2024 Nov 28. doi: 10.1111/jdi.14368. Online ahead of print. J Diabetes Investig. 2024. PMID: 39610144
The oral cavity is a potential reservoir of gram-negative antimicrobial-resistant bacteria, which are correlated with ageing and the number of teeth.
Kawayanagi T, Kawada-Matsuo M, Takeshita T, Nguyen-Tra Le M, Asakawa M, Sugawara Y, Arai C, Ouhara K, Nishi H, Mizuno N, Kawaguchi H, Shiba H, Sugai M, Komatsuzawa H. Kawayanagi T, et al. Among authors: kawaguchi h. Heliyon. 2024 Oct 28;10(21):e39827. doi: 10.1016/j.heliyon.2024.e39827. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39553640 Free PMC article.
How can quantum computing be applied in clinical trial design and optimization?
Doga H, Bose A, Sahin ME, Bettencourt-Silva J, Pham A, Kim E, Andress A, Saxena S, Parida L, Robertus JL, Kawaguchi H, Soliman R, Blankenberg D. Doga H, et al. Among authors: kawaguchi h. Trends Pharmacol Sci. 2024 Oct;45(10):880-891. doi: 10.1016/j.tips.2024.08.005. Epub 2024 Sep 23. Trends Pharmacol Sci. 2024. PMID: 39317621 Free article. Review.
1,768 results